CLINICAL_TRIALS
trial_result
· 2020-12-22
Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia [Phase 2]
Summary
Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of AGN-199201 and AGN-190584 in presbyopia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2020-12-22